National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Spinal Cord Injury: Progress, Promise, and Priorities (2005)
Board on Neuroscience and Behavioral Health (NBH)

Citation Manager

. "5 Progress Toward Neuronal Repair and Regeneration." Spinal Cord Injury: Progress, Promise, and Priorities. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
122
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Spinal Cord Injury: Progress, Promise, and Priorities

cal research efforts from many related fields of neuroscience, bioengineering, and rehabilitative research.

ACUTE INJURY

Reduction of Edema and Free-Radical Attack

A complex series of biochemical reactions that cause ischemia and edema, followed by necrosis and inflammation, occur as a result of a spinal cord injury. Each reaction could provide a target for early intervention and treatment. The key is to pick out, from among the myriad of reactions, the dominant and most specific players and then target them for treatment.

Many different therapeutic approaches have been tested in vitro or with animal models of spinal cord injury (Table 5-1). Some are aimed at

TABLE 5-1 Examples of Strategies to Reduce the Effects of Acute Spinal Cord Injuries Tested with Animal Models

Strategy

Examples of Therapeutic Classes or Agents

Reduce ischemia

  • Antivasospasm agents

  • Protein kinase inhibitors

  • Steroids

  • Prevent disruption to the blood-spinal cord barrier

  • Mild to moderate regional hypothermia

Reduce calcium influx

  • Blockers of ion channels or exchangers

Reduce edema and formation of free radicals

  • Antioxidant enzymes, including free-radical scavengers (e.g., superoxide dismutase, glutathione peroxidase, catalase, and melatonin)

  • Inhibitors of nitric oxide synthase

Control inflammation or enhance protective immunity

  • Steroids and other anti-inflammatories (e.g., COX-2 inhibitors and anti-inflammatory cytokines)

  • Activated macrophages and monocytes

  • Inhibitors of immune cell infiltration of the CNS

  • Antibodies against integrin on the vascular surface to prevent egress of neutrophils

Reduce tissue loss

  • Cell transplantation (e.g., Schwann cells and olfactory ensheathing cells)

  • Increase intercellular cyclic AMP levels

Page
122